Loading...

Welcome to the Regeneron COVID-19 Dashboard

This dashboard contains aggregated information on SARS-CoV-2 (hCoV-19) genomes and associated patient metadata, gathered in partnership with the GISAID initiative.

The goal of the dashboard is to enable scientists to understand the evolution of this emerging coronavirus by monitoring and displaying pertinent information. For example, the dashboard displays the novel mutations in SARS-CoV-2 (hCoV-19) genomes across time and geographical location, which facilitates the identification of a mutation that may increase transmission or virulence.

In addition, there is de-identified patient demographic information such as country of origin, patient status, and age, which provides further insights into the populations most susceptible to the virus.

4,464,094

SARS-CoV-2 (hCoV-19) genomes


October 19, 2021

06:16 AM ET

Last data update


Top Lineages Per Country (Past 12 Weeks)

Loading...

Top* Lineages (Past 12 Weeks)

Lineage Country Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Turkey 88% 31,782 35,944
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Montenegro 84% 62 74
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Estonia 83% 819 989
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Lithuania 83% 3,567 4,310
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Bosnia and Herzegovina 81% 54 67
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
United Kingdom 80% 261,584 327,492
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Austria 79% 1,872 2,360
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Croatia 78% 1,112 1,433
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Norway 72% 4,336 6,060
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Finland 65% 1,078 1,668
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Ireland 63% 5,040 8,000
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Netherlands 61% 6,559 10,771
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Romania 60% 1,409 2,330
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Portugal 60% 2,717 4,543
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Kosovo 59% 256 434
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Poland 57% 2,409 4,253
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
France 56% 11,292 20,039
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Switzerland 56% 10,157 18,111
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Russia 55% 490 884
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Denmark 54% 17,776 32,676
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Sweden 52% 8,116 15,504
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Bulgaria 49% 562 1,150
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Germany 48% 32,216 67,041
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Spain 48% 4,042 8,417
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Slovenia 47% 3,202 6,793
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Greece 47% 621 1,334
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Czechia 47% 1,312 2,820
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Iceland 46% 771 1,661
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Belgium 46% 5,642 12,160
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Italy 46% 5,144 11,087
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Slovakia 46% 1,073 2,350
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Gibraltar 41% 94 229
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Slovenia 40% 2,688 6,793
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Slovakia 37% 864 2,350
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Bulgaria 34% 394 1,150
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Germany 33% 21,895 67,041
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Spain 31% 2,649 8,417
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Belgium 30% 3,615 12,160
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Czechia 29% 818 2,820
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Denmark 28% 9,244 32,676
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Romania 27% 638 2,330
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Poland 27% 1,130 4,253
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Finland 26% 440 1,668
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Russia 26% 231 884
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Italy 25% 2,827 11,087
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Sweden 23% 3,574 15,504
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
France 22% 4,508 20,039
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Greece 22% 300 1,334
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Kosovo 22% 94 434
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Iceland 22% 358 1,661
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Greece 21% 286 1,334
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Gibraltar 21% 49 229
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Switzerland 20% 3,679 18,111
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Norway 20% 1,214 6,060
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Netherlands 18% 1,966 10,771
AY.5AY.5 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (59%), P681R, R158-, T19R
Portugal 16% 749 4,543
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Ireland 16% 1,292 8,000
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Iceland 16% 267 1,661
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Gibraltar 16% 36 229
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Bulgaria 12% 137 1,150
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Slovakia 11% 255 2,350
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Netherlands 11% 1,166 10,771
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
United Kingdom 11% 34,449 327,492
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Guatemala 87% 60 69
AY.34AY.34 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G (84%), D950N (79%), E156G, F157-, P681R, Q677H (74%), R158-, T19R, T95I (66%)
Martinique 79% 94 119
AY.34AY.34 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G (84%), D950N (79%), E156G, F157-, P681R, Q677H (74%), R158-, T19R, T95I (66%)
France (Martinique) 74% 91 123
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Guadeloupe 57% 112 197
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (65%), P681R, R158-, T19R
Canada 51% 15,327 30,292
AY.20AY.20 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (90%), F157-, P681R, R158- (90%), T19R, T95I (70%), V1104L
Mexico 50% 3,214 6,401
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Costa Rica 50% 136 271
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
United States 48% 178,543 375,397
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Sint Maarten 46% 515 1,131
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Sint Maarten 45% 512 1,131
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
U.S. Virgin Islands 37% 48 130
AY.26AY.26 Mutations
ProteinMutations
Spike (RBD)L452R (89%), T478K (90%)
Spike (non-RBD)A222V (79%), D614G, D950N, E156G (83%), F157- (83%), P681R, R158- (83%), T19R, V1264L (74%)
U.S. Virgin Islands 36% 47 130
AY.27AY.27 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D, P681R, Q613H (77%), R158-, T19R
Canada 31% 9,241 30,292
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Puerto Rico 30% 218 719
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Puerto Rico 27% 196 719
AY.26AY.26 Mutations
ProteinMutations
Spike (RBD)L452R (89%), T478K (90%)
Spike (non-RBD)A222V (79%), D614G, D950N, E156G (83%), F157- (83%), P681R, R158- (83%), T19R, V1264L (74%)
Mexico 22% 1,430 6,401
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Guadeloupe 22% 44 197
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (65%), P681R, R158-, T19R
Puerto Rico 18% 129 719
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Mexico 17% 1,080 6,401
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Canada 15% 4,573 30,292
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (65%), P681R, R158-, T19R
United States 15% 55,553 375,397
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (65%), P681R, R158-, T19R
U.S. Virgin Islands 12% 16 130
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
France (Martinique) 12% 15 123
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
United States 11% 42,492 375,397
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
United States 11% 42,404 375,397
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (65%), P681R, R158-, T19R
Costa Rica 11% 30 271
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Puerto Rico 10% 74 719
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Vietnam 98% 235 241
AY.23AY.23 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (84%), F157- (84%), G142D (62%), P681R, R158- (84%), T19R, V1264L (77%)
Singapore 95% 3,158 3,324
AY.29AY.29 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D, P681R, R158-, T19R, T95I
Japan 93% 19,790 21,327
AY.33AY.33 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (72%), P681R, R158- (51%), T19R
Maldives 89% 226 255
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
South Korea 87% 2,203 2,540
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Pakistan 76% 180 237
AY.23AY.23 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (84%), F157- (84%), G142D (62%), P681R, R158- (84%), T19R, V1264L (77%)
Indonesia 66% 558 841
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Hong Kong 64% 72 113
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Nepal 56% 47 84
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Cambodia 52% 253 488
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Israel 51% 96 189
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Kazakhstan 50% 46 92
AY.23AY.23 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (84%), F157- (84%), G142D (62%), P681R, R158- (84%), T19R, V1264L (77%)
Malaysia 50% 716 1,434
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Jordan 49% 47 96
AY.28AY.28 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, A701S (88%), A1078S, D614G, D950N, E156G, F157-, G142D, P681R, R158-, T19R
Sri Lanka 48% 278 581
AY.16AY.16 Mutations
ProteinMutations
Spike (RBD)T478K (63%)
Spike (non-RBD)D614G, D950N, E156G (81%), F157- (84%), G142D (77%), P681R, R158- (81%), T19R
Kazakhstan 48% 44 92
AY.30AY.30 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (81%), F157- (81%), P681R, R158- (81%), T19R
Thailand 46% 311 674
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Bangladesh 42% 157 372
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Bahrain 42% 135 321
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
India 42% 1,355 3,248
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Jordan 42% 40 96
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Bangladesh 41% 154 372
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Malaysia 38% 543 1,434
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Kuwait 34% 23 67
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Sri Lanka 33% 189 581
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Thailand 32% 217 674
AY.30AY.30 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (81%), F157- (81%), P681R, R158- (81%), T19R
Cambodia 32% 157 488
AY.26AY.26 Mutations
ProteinMutations
Spike (RBD)L452R (89%), T478K (90%)
Spike (non-RBD)A222V (79%), D614G, D950N, E156G (83%), F157- (83%), P681R, R158- (83%), T19R, V1264L (74%)
Bahrain 32% 102 321
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
India 23% 747 3,248
AY.33AY.33 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (72%), P681R, R158- (51%), T19R
Nepal 23% 19 84
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Pakistan 21% 49 237
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (88%), E156G, F157-, P681R, R158-, T19R, T791I
Israel 21% 39 189
AY.26AY.26 Mutations
ProteinMutations
Spike (RBD)L452R (89%), T478K (90%)
Spike (non-RBD)A222V (79%), D614G, D950N, E156G (83%), F157- (83%), P681R, R158- (83%), T19R, V1264L (74%)
Kuwait 19% 13 67
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Kuwait 18% 12 67
AY.24AY.24 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (75%), F157- (75%), P681R, R158- (75%), T19R
Indonesia 18% 150 841
AY.33AY.33 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (72%), P681R, R158- (51%), T19R
India 16% 506 3,248
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Sri Lanka 13% 77 581
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Bahrain 12% 40 321
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Israel 11% 20 189
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
New Zealand 97% 1,329 1,373
AY.30AY.30 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (81%), F157- (81%), P681R, R158- (81%), T19R
Australia 62% 7,051 11,316
AY.24AY.24 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (75%), F157- (75%), P681R, R158- (75%), T19R
Papua New Guinea 46% 69 149
AY.23AY.23 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (84%), F157- (84%), G142D (62%), P681R, R158- (84%), T19R, V1264L (77%)
Papua New Guinea 44% 65 149
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Australia 32% 3,675 11,316
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Suriname 64% 79 124
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Brazil 62% 5,912 9,541
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Bonaire 60% 145 243
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Curacao 58% 122 210
B.1.621B.1.621 Mutations
ProteinMutations
Spike (RBD)E484K, N501Y, R346K
Spike (non-RBD)D614G, D950N (88%), P681H, T95I, Y144S (79%), Y144T (67%), Y145N (88%), Y145S (61%), ins143T (79%), ins145N (65%)
Colombia 52% 558 1,065
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Paraguay 48% 24 50
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
French Guiana 43% 83 191
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Bonaire 37% 90 243
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
French Guiana 34% 65 191
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (65%), P681R, R158-, T19R
Aruba 33% 367 1,118
B.1B.1 Mutations
ProteinMutations
Spike (non-RBD)D614G
Ecuador 32% 26 81
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Argentina 29% 102 351
AY.5AY.5 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (59%), P681R, R158-, T19R
Paraguay 28% 14 50
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Aruba 28% 309 1,118
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Curacao 27% 56 210
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Suriname 26% 32 124
C.37C.37 Mutations
ProteinMutations
Spike (RBD)F490S, L452Q
Spike (non-RBD)D253N (87%), D614G, G75V, G252- (87%), L249- (86%), P251- (87%), R246- (86%), S247- (86%), T76I, T250- (87%), T859N, Y248- (86%)
Peru 24% 424 1,732
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Chile 21% 759 3,572
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Chile 21% 739 3,572
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Aruba 20% 228 1,118
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (65%), P681R, R158-, T19R
Chile 18% 649 3,572
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Peru 17% 291 1,732
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Aruba 17% 185 1,118
C.37C.37 Mutations
ProteinMutations
Spike (RBD)F490S, L452Q
Spike (non-RBD)D253N (87%), D614G, G75V, G252- (87%), L249- (86%), P251- (87%), R246- (86%), S247- (86%), T76I, T250- (87%), T859N, Y248- (86%)
Argentina 17% 58 351
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Argentina 15% 54 351
B.1.621B.1.621 Mutations
ProteinMutations
Spike (RBD)E484K, N501Y, R346K
Spike (non-RBD)D614G, D950N (88%), P681H, T95I, Y144S (79%), Y144T (67%), Y145N (88%), Y145S (61%), ins143T (79%), ins145N (65%)
Chile 15% 545 3,572
P.1.12P.1.12 Mutations
ProteinMutations
Spike (RBD)E484K (86%), K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S (88%), T20N, T1027I, V1176F
Peru 15% 263 1,732
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
French Guiana 14% 26 191
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Peru 14% 234 1,732
P.1.7P.1.7 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, P681H, R190S, T20N, T1027I, V1176F
Peru 13% 225 1,732
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Ecuador 11% 9 81
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Ecuador 11% 9 81
AY.5AY.5 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (59%), P681R, R158-, T19R
Curacao 11% 23 210
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
AY.36AY.36 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (85%), F157- (85%), P681R, R158- (85%), T19R, T95I (73%), V1104L
Nigeria 70% 582 831
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Reunion 63% 329 526
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Seychelles 62% 71 114
AY.33AY.33 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (72%), P681R, R158- (51%), T19R
Botswana 62% 274 440
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
France (Réunion Island) 58% 34 59
AY.16AY.16 Mutations
ProteinMutations
Spike (RBD)T478K (63%)
Spike (non-RBD)D614G, D950N, E156G (81%), F157- (84%), G142D (77%), P681R, R158- (81%), T19R
Kenya 42% 113 270
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
South Africa 40% 1,054 2,650
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Kenya 33% 88 270
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Botswana 30% 133 440
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
France (Réunion Island) 29% 17 59
AY.7.1AY.7.1 Mutations
ProteinMutations
Spike (RBD)L452R (85%), T478K (85%)
Spike (non-RBD)D614G, D950N, P681R, T19R (87%)
Ghana 26% 16 62
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Ghana 24% 15 62
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Ghana 18% 11 62
AY.32AY.32 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (81%), F157- (82%), P681R, R158- (81%), T19R, T572I (77%)
South Africa 16% 436 2,650
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
South Africa 16% 428 2,650
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Nigeria 15% 126 831
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Reunion 14% 73 526
AY.36AY.36 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (85%), F157- (85%), P681R, R158- (85%), T19R, T95I (73%), V1104L
Ghana 13% 8 62
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Kenya 12% 32 270
AY.7.1AY.7.1 Mutations
ProteinMutations
Spike (RBD)L452R (85%), T478K (85%)
Spike (non-RBD)D614G, D950N, P681R, T19R (87%)
Seychelles 11% 12 114
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage State Percent Lineage Count Total Count
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (65%), P681R, R158-, T19R
Guam 77% 20 26
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Idaho 66% 2,516 3,792
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Hawaii 64% 697 1,097
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Montana 60% 1,148 1,908
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Nevada 59% 3,037 5,125
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Utah 59% 4,133 7,005
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
California 59% 31,673 53,811
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Vermont 58% 2,204 3,796
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
New Mexico 57% 2,059 3,610
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Virginia 56% 2,968 5,312
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
North Carolina 54% 6,588 12,108
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
South Carolina 54% 2,761 5,097
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Arizona 54% 4,750 8,769
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
West Virginia 54% 2,523 4,709
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Delaware 53% 706 1,322
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Oregon 53% 2,923 5,517
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Florida 52% 9,111 17,505
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
New Hampshire 52% 644 1,250
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
New York 51% 8,777 17,045
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
District of Columbia 51% 910 1,770
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Pennsylvania 51% 2,485 4,861
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Maine 50% 747 1,503
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Alaska 50% 1,491 3,001
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
New Jersey 49% 3,496 7,164
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Massachusetts 48% 11,778 24,326
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
South Dakota 48% 374 773
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Georgia 48% 5,776 12,072
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Rhode Island 47% 1,048 2,251
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Maryland 46% 2,887 6,271
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Alabama 45% 1,980 4,376
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Texas 44% 8,640 19,552
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Northern Mariana Islands 43% 10 23
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Illinois 43% 3,466 7,975
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Connecticut 43% 1,890 4,369
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Ohio 43% 3,253 7,636
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Wisconsin 42% 2,652 6,247
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Indiana 42% 2,330 5,536
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Kentucky 42% 2,188 5,242
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
North Dakota 42% 588 1,413
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Washington 41% 5,249 12,762
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Arkansas 38% 936 2,445
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Oklahoma 38% 368 971
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Missouri 38% 1,568 4,146
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Michigan 37% 1,621 4,379
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Colorado 37% 6,206 16,770
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Iowa 36% 1,320 3,617
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Kansas 36% 1,164 3,240
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Louisiana 35% 1,530 4,404
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Wyoming 34% 1,450 4,309
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Minnesota 32% 5,590 17,212
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Tennessee 31% 2,855 9,113
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Nebraska 31% 1,025 3,339
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Mississippi 27% 919 3,413
*Criteria: Minimum of 20 samples per state.

Top Emerging* Lineages (Past 12 Weeks)

Lineage Country 2-Week Period Change Previous Support Current Support
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Slovakia 2021-10-04 23% -> 62% (+39%) 22 / 97 29 / 47
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Turkey 2021-08-23 0% -> 36% (+36%) 144 / 30,581 478 / 1,319
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Russia 2021-09-20 23% -> 55% (+32%) 68 / 298 79 / 143
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Slovenia 2021-09-20 45% -> 76% (+31%) 898 / 1,989 174 / 230
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Romania 2021-09-06 15% -> 37% (+22%) 80 / 540 327 / 880
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
France 2021-10-04 37% -> 59% (+21%) 684 / 1,841 188 / 321
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Iceland 2021-08-23 17% -> 37% (+21%) 210 / 1,263 148 / 398
AY.26AY.26 Mutations
ProteinMutations
Spike (RBD)L452R (89%), T478K (90%)
Spike (non-RBD)A222V (79%), D614G, D950N, E156G (83%), F157- (83%), P681R, R158- (83%), T19R, V1264L (74%)
Czechia 2021-09-20 7% -> 26% (+19%) 62 / 952 107 / 412
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Denmark 2021-10-04 29% -> 46% (+16%) 1,395 / 4,764 1,723 / 3,786
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Finland 2021-08-23 57% -> 73% (+16%) 572 / 1,006 360 / 495
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Sweden 2021-10-04 32% -> 48% (+16%) 512 / 1,616 58 / 122
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Greece 2021-08-23 9% -> 22% (+13%) 16 / 175 72 / 321
AY.33AY.33 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (72%), P681R, R158- (51%), T19R
Netherlands 2021-10-04 5% -> 18% (+13%) 83 / 1,649 15 / 83
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Norway 2021-10-04 24% -> 37% (+13%) 189 / 782 20 / 54
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Poland 2021-09-20 21% -> 33% (+12%) 262 / 1,242 376 / 1,146
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Gibraltar 2021-08-23 17% -> 28% (+11%) 23 / 137 26 / 92
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Switzerland 2021-10-04 19% -> 31% (+11%) 547 / 2,809 69 / 223
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Belgium 2021-09-06 43% -> 54% (+11%) 1,529 / 3,564 1,206 / 2,228
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Spain 2021-10-04 28% -> 39% (+11%) 213 / 753 44 / 113
AY.4.1AY.4.1 Mutations
ProteinMutations
Spike (RBD)G446V (52%), L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R (87%), R158-, T19R, T95I (90%)
Kosovo 2021-09-06 2% -> 12% (+10%) 1 / 64 25 / 216
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Germany 2021-08-23 39% -> 47% (+8%) 5,080 / 13,079 9,046 / 19,119
AY.5AY.5 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (59%), P681R, R158-, T19R
Croatia 2021-09-06 6% -> 14% (+8%) 38 / 631 5 / 36
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Italy 2021-10-04 44% -> 52% (+7%) 841 / 1,893 393 / 758
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Lithuania 2021-09-06 80% -> 86% (+6%) 953 / 1,196 743 / 869
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Portugal 2021-09-06 6% -> 12% (+5%) 71 / 1,098 127 / 1,089
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Austria 2021-08-23 76% -> 82% (+5%) 469 / 614 758 / 930
AY.33AY.33 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (72%), P681R, R158- (51%), T19R
Estonia 2021-08-23 1% -> 4% (+2%) 5 / 371 13 / 369
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
AY.26AY.26 Mutations
ProteinMutations
Spike (RBD)L452R (89%), T478K (90%)
Spike (non-RBD)A222V (79%), D614G, D950N, E156G (83%), F157- (83%), P681R, R158- (83%), T19R, V1264L (74%)
U.S. Virgin Islands 2021-08-23 9% -> 78% (+69%) 6 / 67 21 / 27
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Puerto Rico 2021-09-20 6% -> 36% (+30%) 12 / 185 13 / 36
AY.34AY.34 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G (84%), D950N (79%), E156G, F157-, P681R, Q677H (74%), R158-, T19R, T95I (66%)
France (Martinique) 2021-08-23 62% -> 86% (+24%) 30 / 48 25 / 29
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Guadeloupe 2021-09-06 47% -> 64% (+17%) 31 / 66 38 / 59
AY.34AY.34 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G (84%), D950N (79%), E156G, F157-, P681R, Q677H (74%), R158-, T19R, T95I (66%)
Martinique 2021-09-06 69% -> 84% (+15%) 22 / 32 21 / 25
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Sint Maarten 2021-09-20 49% -> 62% (+14%) 72 / 148 71 / 114
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (65%), P681R, R158-, T19R
Costa Rica 2021-09-20 5% -> 17% (+12%) 3 / 60 6 / 35
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
United States 2021-10-04 51% -> 61% (+11%) 24,809 / 48,886 3,791 / 6,173
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Canada 2021-09-20 14% -> 19% (+6%) 756 / 5,504 90 / 463
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Nepal 2021-09-20 28% -> 81% (+53%) 12 / 43 17 / 21
AY.28AY.28 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, A701S (88%), A1078S, D614G, D950N, E156G, F157-, G142D, P681R, R158-, T19R
Sri Lanka 2021-10-04 33% -> 81% (+48%) 24 / 73 38 / 47
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Pakistan 2021-08-23 43% -> 91% (+48%) 33 / 76 111 / 122
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Malaysia 2021-09-20 36% -> 79% (+43%) 122 / 341 19 / 24
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Japan 2021-09-06 3% -> 45% (+43%) 137 / 4,933 70 / 154
AY.23AY.23 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (84%), F157- (84%), G142D (62%), P681R, R158- (84%), T19R, V1264L (77%)
Indonesia 2021-09-20 53% -> 85% (+32%) 80 / 151 33 / 39
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
India 2021-09-20 62% -> 89% (+26%) 307 / 494 77 / 87
AY.30AY.30 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (81%), F157- (81%), P681R, R158- (81%), T19R
Cambodia 2021-09-20 21% -> 47% (+26%) 28 / 132 50 / 106
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Thailand 2021-09-20 34% -> 59% (+24%) 54 / 157 44 / 75
AY.26AY.26 Mutations
ProteinMutations
Spike (RBD)L452R (89%), T478K (90%)
Spike (non-RBD)A222V (79%), D614G, D950N, E156G (83%), F157- (83%), P681R, R158- (83%), T19R, V1264L (74%)
Bahrain 2021-09-20 26% -> 47% (+21%) 58 / 227 44 / 94
AY.24AY.24 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (75%), F157- (75%), P681R, R158- (75%), T19R
Hong Kong 2021-08-23 4% -> 21% (+18%) 1 / 27 10 / 47
AY.23AY.23 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (84%), F157- (84%), G142D (62%), P681R, R158- (84%), T19R, V1264L (77%)
Singapore 2021-08-23 84% -> 96% (+12%) 552 / 655 968 / 1,007
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Bangladesh 2021-09-20 34% -> 45% (+11%) 30 / 88 10 / 22
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Jordan 2021-09-20 41% -> 47% (+7%) 11 / 27 27 / 57
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Vietnam 2021-08-23 93% -> 99% (+6%) 51 / 55 128 / 129
AY.33AY.33 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (72%), P681R, R158- (51%), T19R
Maldives 2021-09-20 86% -> 91% (+5%) 90 / 105 89 / 98
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
South Korea 2021-09-06 86% -> 91% (+5%) 907 / 1,057 505 / 556
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
AY.30AY.30 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (81%), F157- (81%), P681R, R158- (81%), T19R
Australia 2021-09-20 40% -> 77% (+38%) 1,220 / 3,068 889 / 1,149
AY.24AY.24 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (75%), F157- (75%), P681R, R158- (75%), T19R
Papua New Guinea 2021-09-06 38% -> 73% (+35%) 39 / 102 19 / 26
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
New Zealand 2021-08-23 88% -> 99% (+10%) 153 / 173 606 / 615
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
French Guiana 2021-09-06 12% -> 71% (+60%) 3 / 26 45 / 63
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Suriname 2021-08-23 30% -> 82% (+52%) 13 / 43 46 / 56
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Peru 2021-09-20 21% -> 49% (+28%) 97 / 468 18 / 37
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Chile 2021-09-06 14% -> 34% (+20%) 156 / 1,096 389 / 1,145
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (65%), P681R, R158-, T19R
Aruba 2021-08-23 25% -> 45% (+20%) 160 / 628 118 / 261
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Bonaire 2021-08-23 47% -> 66% (+19%) 21 / 45 40 / 61
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Argentina 2021-08-23 24% -> 39% (+15%) 40 / 167 59 / 152
AY.33AY.33 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (72%), P681R, R158- (51%), T19R
Brazil 2021-09-20 0% -> 12% (+12%) 13 / 2,978 46 / 375
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Curacao 2021-09-06 23% -> 33% (+9%) 11 / 47 19 / 58
AY.20AY.20 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (90%), F157-, P681R, R158- (90%), T19R, T95I (70%), V1104L
Colombia 2021-09-06 1% -> 8% (+7%) 5 / 496 5 / 66
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Botswana 2021-09-06 25% -> 81% (+56%) 67 / 265 55 / 68
AY.32AY.32 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (81%), F157- (82%), P681R, R158- (81%), T19R, T572I (77%)
South Africa 2021-09-20 13% -> 46% (+33%) 73 / 572 59 / 129
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Reunion 2021-09-06 17% -> 43% (+26%) 27 / 158 34 / 79
AY.36AY.36 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (85%), F157- (85%), P681R, R158- (85%), T19R, T95I (73%), V1104L
Nigeria 2021-08-23 64% -> 77% (+13%) 289 / 452 239 / 309
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Kenya 2021-09-06 28% -> 39% (+10%) 41 / 145 17 / 44
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Seychelles 2021-08-23 6% -> 13% (+8%) 4 / 69 6 / 45
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage State 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Minnesota 2021-10-04 26% -> 60% (+35%) 1,096 / 4,254 58 / 96
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Maine 2021-10-04 44% -> 75% (+31%) 59 / 133 15 / 20
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Georgia 2021-10-04 5% -> 36% (+30%) 49 / 912 10 / 28
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Ohio 2021-10-04 48% -> 75% (+27%) 373 / 771 30 / 40
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Michigan 2021-09-20 37% -> 63% (+26%) 486 / 1,303 470 / 744
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Vermont 2021-08-23 41% -> 66% (+25%) 234 / 569 560 / 844
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Tennessee 2021-09-20 30% -> 51% (+22%) 1,012 / 3,415 95 / 185
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Colorado 2021-10-04 46% -> 66% (+21%) 829 / 1,819 110 / 166
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Oklahoma 2021-09-20 35% -> 55% (+20%) 118 / 340 17 / 31
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Wisconsin 2021-10-04 56% -> 76% (+20%) 453 / 810 59 / 78
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Massachusetts 2021-08-23 29% -> 48% (+19%) 1,411 / 4,918 2,893 / 6,029
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Missouri 2021-09-20 38% -> 58% (+19%) 489 / 1,274 110 / 191
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
South Carolina 2021-09-20 53% -> 70% (+17%) 687 / 1,307 312 / 447
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Florida 2021-09-20 45% -> 61% (+16%) 2,042 / 4,520 1,031 / 1,689
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Mississippi 2021-10-04 6% -> 21% (+16%) 24 / 430 6 / 28
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
District of Columbia 2021-09-20 46% -> 61% (+15%) 250 / 547 182 / 300
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Arkansas 2021-09-20 41% -> 55% (+14%) 138 / 335 56 / 101
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Oregon 2021-09-06 51% -> 64% (+14%) 830 / 1,642 570 / 887
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Washington 2021-09-20 26% -> 40% (+14%) 760 / 2,930 703 / 1,774
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
New Hampshire 2021-09-20 7% -> 20% (+14%) 25 / 367 55 / 269
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
South Dakota 2021-08-23 44% -> 57% (+13%) 107 / 242 148 / 260
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Illinois 2021-10-04 7% -> 19% (+13%) 51 / 752 6 / 31
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Pennsylvania 2021-09-20 48% -> 60% (+12%) 655 / 1,353 655 / 1,086
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Hawaii 2021-08-23 57% -> 69% (+12%) 212 / 373 314 / 458
AY.26AY.26 Mutations
ProteinMutations
Spike (RBD)L452R (89%), T478K (90%)
Spike (non-RBD)A222V (79%), D614G, D950N, E156G (83%), F157- (83%), P681R, R158- (83%), T19R, V1264L (74%)
Utah 2021-10-04 4% -> 16% (+12%) 16 / 392 6 / 38
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Maryland 2021-09-20 45% -> 56% (+11%) 555 / 1,232 386 / 687
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (65%), P681R, R158-, T19R
Rhode Island 2021-10-04 20% -> 31% (+11%) 83 / 414 9 / 29
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Indiana 2021-09-20 40% -> 51% (+11%) 641 / 1,589 601 / 1,176
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Arizona 2021-09-06 49% -> 60% (+10%) 1,186 / 2,407 1,316 / 2,202
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Alabama 2021-09-20 38% -> 49% (+10%) 375 / 979 52 / 107
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
North Dakota 2021-08-23 41% -> 52% (+10%) 212 / 511 125 / 242
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Nevada 2021-09-20 7% -> 16% (+9%) 85 / 1,248 203 / 1,254
AY.16AY.16 Mutations
ProteinMutations
Spike (RBD)T478K (63%)
Spike (non-RBD)D614G, D950N, E156G (81%), F157- (84%), G142D (77%), P681R, R158- (81%), T19R
North Carolina 2021-10-04 0% -> 10% (+9%) 3 / 996 6 / 63
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Idaho 2021-09-20 13% -> 21% (+9%) 112 / 888 119 / 561
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Kansas 2021-09-06 33% -> 42% (+8%) 316 / 950 392 / 942
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Connecticut 2021-09-20 10% -> 18% (+8%) 125 / 1,268 114 / 631
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Texas 2021-09-20 42% -> 50% (+8%) 2,632 / 6,323 710 / 1,428
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Iowa 2021-10-04 35% -> 43% (+8%) 192 / 549 21 / 49
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R, T95I (62%)
Nebraska 2021-09-06 19% -> 27% (+7%) 199 / 1,041 230 / 866
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
New Jersey 2021-09-20 47% -> 54% (+7%) 964 / 2,069 667 / 1,240
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Virginia 2021-09-20 59% -> 66% (+7%) 828 / 1,411 336 / 511
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
Delaware 2021-09-06 49% -> 56% (+7%) 129 / 261 137 / 244
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (65%), P681R, R158-, T19R
West Virginia 2021-09-20 12% -> 19% (+7%) 173 / 1,395 85 / 448
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Wyoming 2021-09-06 11% -> 18% (+7%) 149 / 1,297 181 / 1,003
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (76%), P681R, R158-, T19R
California 2021-10-04 60% -> 66% (+6%) 3,803 / 6,387 1,014 / 1,541
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (65%), P681R, R158-, T19R
New Mexico 2021-09-20 14% -> 20% (+6%) 102 / 723 108 / 535
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (56%), P681R, R158-, T19R
Louisiana 2021-09-20 15% -> 21% (+6%) 79 / 527 61 / 290
AY.7.1AY.7.1 Mutations
ProteinMutations
Spike (RBD)L452R (85%), T478K (85%)
Spike (non-RBD)D614G, D950N, P681R, T19R (87%)
New York 2021-10-04 2% -> 5% (+3%) 55 / 2,906 18 / 348
AY.24AY.24 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (75%), F157- (75%), P681R, R158- (75%), T19R
Montana 2021-09-06 1% -> 2% (+2%) 2 / 360 17 / 729
*Criteria: >= +5% or >= 2x fold change between 2-week periods with >= 20 samples.

Data Timeline

Loading...
Loading...

Dashboard Timeline

April 16, 2021
08:50PM

Dashboard UI/graphs updated

Added emerging lineages tracking and top lineages tracking per US state to home page
April 16, 2021
08:00PM

Dashboard backend pipeline overhauled

Overhauled backend pipeline to automatically download and QC data from GISAID daily
April 05, 2021
03:30PM

Dashboard UI/graphs updated

Added top and emerging lineage maps and graphs. Overhauled home page
March 23, 2021
06:00PM

Dashboard performance overhauled

Added caching and refactored all graphs for performance before public release
November 13, 2020
04:00PM

Dashboard UI/graphs updated

Broad-scale update across the entire dashboard to prepare for its launch onto the world wide web!
June 15, 2020
12:00AM

Dashboard graphs upgraded

Migrated dashboard graphs from Plotly to ECharts
June 04, 2020
08:06PM

Dashboard data source changed

Upgraded dashboard to use a database vs flat files. 3x reduction in load time
June 02, 2020
12:18PM

Dashboard UI upgraded

Overhauled dashboard user interface to use bs4dash
May 26, 2020
12:00AM

Variant tracking expanded

Began tracking variants in genes ORF1a and ORF1b
May 11, 2020
12:00AM

Variant tracking expanded

Began tracking variants in genes E, M, N, ORF3a, ORF7a, ORF8, and ORF10
April 27, 2020
12:00AM

Phylogenetic analysis added

Added tab containing viral genome evolutionary relationships
April 03, 2020
12:00AM

Automated QC pipeline created

Cleans up metadata fields such as age, collection date, gender, etc
April 02, 2020
10:36AM

First version of dashboard created

Created first version with shinydashboard. Data is ingested from flat files
March 31, 2020
12:00AM

Patient metadata tracking started

Began downloading patient metadata for all genomes
January 10, 2020
12:00AM

First data downloaded

Began downloading genomes from GISAID and subsequent variant calling



Loading...

Loading...